Combined modality treatment for poor prognosis stages I and II Hodgkin's disease
- 31 July 1996
- journal article
- Published by Elsevier BV in Seminars in Radiation Oncology
- Vol. 6 (3), 185-195
- https://doi.org/10.1016/s1053-4296(96)80015-4
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?Blood, 1994
- Long-Term Complications of Laparotomy in Hodgkinʼs DiseaseAnnals of Surgery, 1994
- Controversies in the management of early stage Hodgkin's disease [see comments]Blood, 1994
- Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.Journal of Clinical Oncology, 1993
- Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.Journal of Clinical Oncology, 1993
- The EORTC trials for limited stage Hodgkin's diseaseEuropean Journal Of Cancer, 1992
- Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987Blood, 1989
- SPLENECTOMY IN HODGKIN'S DISEASE AND SECOND LEUKAEMIASThe Lancet, 1987
- A multivariate analysis of prognostic factors in early stage hodgkin's diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's diseaseEuropean Journal of Cancer (1965), 1979